ijerph-logo

Journal Browser

Journal Browser

Special Issue "Impact of Medicinal Cannabis on Clinical, Economic, and Patient Reported Outcomes"

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Health Economics".

Deadline for manuscript submissions: 30 April 2022.

Special Issue Editors

Dr. Daniel A. Erku
E-Mail Website
Guest Editor
Centre for Applied Health Economics, Griffith University, Nathan, Queensland 4000, Australia
Interests: medicinal cannabis; health economics; patient preference; pharmaceutical health services research; tobacco control; cancer prevention and control
Dr. Yvonne Bonomo
E-Mail Website
Guest Editor
1. Department of Addiction Medicine, St Vincent's Hospital Melbourne, Melbourne, Victoria 3000, Australia
2. Division of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Victoria 3000, Australia
Interests: addiction including medicinal cannabis

Special Issue Information

Dear Colleagues,

Patient interest in the use of cannabis and cannabinoids to treat a variety of conditions has increased over the last decade. Increased patient demand has also been accompanied by renewed scientific interest in the therapeutic effects of cannabis, and several clinical trials have recently evaluated the medical use of cannabinoids. Although the evidence base is limited and inconsistent, findings from systematic reviews of currently available controlled clinical trials suggest that cannabinoids, when used as either adjunctive treatment or a drug of last resort, relieve some of the symptoms of some illnesses (e.g., neuropathic pain and spasticity in multiple sclerosis, chronic non-cancer pain, intractable childhood epilepsy). Medicine regulatory authorities in certain countries have already granted marketing authorisations, on the basis of an evolving yet limited evidence base, to a wide variety of plant-derived and synthetic cannabinoid-containing preparations for various indications. These products predominantly contain tetrahydrocannabinol (THC) and/or cannabidiol (CBD) in various concentrations and dosage forms.

This Special Issue will add to the knowledge base and advance our international understanding of medicinal cannabis by generating clinical, economic, and patient reported outcomes to inform policy and clinical practice on the use of cannabis-based medicines. We encourage you to submit original, empirical studies, systematic reviews, meta-analyses, network meta-analyses, qualitative studies, health policy analysis and media content analysis. Interdisciplinary and multi-country collaborative research are particularly welcome. Examples of manuscripts include (but are not limited to) the following areas:

Clinical pharmacology

  • Acceptability, safety, effectiveness (and PK profile) of medicinal cannabis for various disease conditions including in the substance withdrawal context;

Health economics and patient reported outcomes

  • Public and patient preference for the availability and use of medicinal cannabis;
  • Impact of medicinal cannabis on patient reported outcomes such as health-related quality of life (HRQoL);
  • Cost–effectiveness of medicinal cannabis for the management of refractory symptoms associated with chronic conditions (cost–utility analyses, value of information analyses, etc.)

Health service research

  • Barriers to patient access to medicinal cannabis;
  • Beliefs, knowledge, concerns, and self-reported practices of health professionals regarding medicinal cannabis.

If you have an idea but are not certain whether this falls into the scope of this Special Issue, you may contact the Guest Editor: Dr. Daniel Erku.

Dr. Daniel A. Erku
Dr. Yvonne Bonomo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cannabis
  • medicinal cannabis
  • synthetic cannabinoids
  • pharmacology
  • toxicology
  • pharmacovigilance
  • health economics
  • health services research

Published Papers

This special issue is now open for submission.
Back to TopTop